Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Joyner

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
European Heart Journal|August 21, 2008
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesAndrzej Budaj, John W Eikelboom, Shamir R Mehta, et al.
European Heart Journal|April 30, 2008
Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) studyDavinder S Jassal, James W Tam, Kapil M Bhagirath, et al.
The New England Journal of Medicine|September 8, 2010
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, Shamir R Mehta, Jean-Pierre Bassand, et al.
Journal of the American College of Cardiology|July 25, 2009
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trialSanjit S Jolly, David P Faxon, Keith A A Fox, et al.
European Heart Journal|August 23, 2000
Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ SyndromesM D Flather, J I Weitz, S Yusuf, et al.
Lancet (London, England)|April 8, 2011
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trialSanjit S Jolly, Salim Yusuf, John Cairns, et al.
The New England Journal of Medicine|September 1, 2009
Dabigatran versus warfarin in patients with atrial fibrillationStuart J Connolly, Michael D Ezekowitz, Salim Yusuf, et al.
Lancet (London, England)|September 7, 2010
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trialShamir R Mehta, Jean-Francois Tanguay, John W Eikelboom, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
European Heart Journal|August 21, 2008
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromesAndrzej Budaj, John W Eikelboom, Shamir R Mehta, et al.
European Heart Journal|April 30, 2008
Association of mitral annular calcification and aortic valve morphology: a substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) studyDavinder S Jassal, James W Tam, Kapil M Bhagirath, et al.
The New England Journal of Medicine|September 8, 2010
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes, Shamir R Mehta, Jean-Pierre Bassand, et al.
Journal of the American College of Cardiology|July 25, 2009
Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trialSanjit S Jolly, David P Faxon, Keith A A Fox, et al.
European Heart Journal|August 23, 2000
Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ SyndromesM D Flather, J I Weitz, S Yusuf, et al.
Lancet (London, England)|April 8, 2011
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trialSanjit S Jolly, Salim Yusuf, John Cairns, et al.
The New England Journal of Medicine|September 1, 2009
Dabigatran versus warfarin in patients with atrial fibrillationStuart J Connolly, Michael D Ezekowitz, Salim Yusuf, et al.
Lancet (London, England)|September 7, 2010
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trialShamir R Mehta, Jean-Francois Tanguay, John W Eikelboom, et al.
Pageof 7